← Back to Search

Peer mentorship for Suicidal Thoughts (PREVAIL Trial)

N/A
Waitlist Available
Led By Paul Pfeiffer, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights

PREVAIL Trial Summary

This trial will test a promising, scalable intervention with a novel approach to addressing the risk factors advocated by the Surgeon General for reducing suicide attempts and suicidal ideation among recently hospitalized adult psychiatric patients at high risk for suicide.

Eligible Conditions
  • Suicidal Thoughts

PREVAIL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Suicide attempts (measured by the Columbia Suicide Severity Rating Scale)
Secondary outcome measures
Self efficacy to avoid suicidal action (measured by the Self Efficacy to Avoid Suicidal Action Scale)
Feeling suicidal (finding)
Suicide attempts (measured by the medical record)
Other outcome measures
Burdensomeness (measured by the Burdensomeness sub scale of the Interpersonal Needs Questionnaire (INQ))
Depression (measured by the Patient Health Questionnaire (PHQ-9))
Subfascicular nucleus
+13 more

PREVAIL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer Mentorship interventionExperimental Treatment1 Intervention
A Peer Specialist will be making weekly follow-up contact with study participants in the community or by telephone for 3 months following hospital discharge. The content of the peer mentorship interactions will be based on the manual developed by the study team and will address protective factors such as hope and belongingness.
Group II: Enhanced Usual Care (EUC)Active Control1 Intervention
The EUC condition will consist of a "caring message" from the study team via e-mail or text message (based on the participant's preference) 24-72 hours after discharge. An example message is, "We hope things are going well for you since you left the hospital. If you wish to reply, we'd be glad to hear from you". A list of local mental health resources will be available if participants reply and during the 3 and 6-month follow-up assessments. The EUC condition is modeled on prior studies of caring letters and brief contacts by health professionals after suicidal crisis and national recommendations to provide post-crisis follow-up contacts.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer mentorship
2018
N/A
~800

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,652 Total Patients Enrolled
1 Trials studying Suicidal Thoughts
240 Patients Enrolled for Suicidal Thoughts
University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,461 Total Patients Enrolled
Paul Pfeiffer, MDPrincipal InvestigatorUniversity of Michigan

Media Library

Enhanced Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT03373916 — N/A
Suicidal Thoughts Research Study Groups: Peer Mentorship intervention, Enhanced Usual Care (EUC)
Suicidal Thoughts Clinical Trial 2023: Enhanced Usual Care Highlights & Side Effects. Trial Name: NCT03373916 — N/A
Enhanced Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT03373916 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies open to participants in this trial?

"Per the information found on clinicaltrials.gov, recruiting for this medical trial has been suspended since July 19th 2022. Initially posted in June 2018, it is no longer seeking individuals to participate; however there are still 217 other trials actively enrolling participants at present."

Answered by AI
~67 spots leftby Apr 2025